|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,360.00 GBX | +0.37% |
|
+0.75% | +8.17% |
| 01-27 | British Equities Rally Amid Leasehold System Overhaul; HSBC Shares Hit Record High | MT |
| 01-27 | Siegfried Raises the Stakes, Crédit Agricole Builds Momentum... Dr. Martens Stumbles |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.93 | 7.84 | 6.83 | 8.26 | 8.75 | |||||
Return on Total Capital | 10.09 | 10.12 | 8.94 | 10.92 | 11.57 | |||||
Return On Equity % | 14.22 | 14.23 | 13.82 | 12.89 | 14.14 | |||||
Return on Common Equity | 14.22 | 14.23 | 13.82 | 12.89 | 14.14 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.18 | 13.99 | 12.95 | 14.42 | 15.42 | |||||
SG&A Margin | 7.19 | 6.96 | 7.06 | 7.49 | 7.8 | |||||
EBITDA Margin % | 9.72 | 9.42 | 8.22 | 9.44 | 10.12 | |||||
EBITA Margin % | 6.99 | 7.04 | 5.89 | 6.92 | 7.62 | |||||
EBIT Margin % | 6.81 | 6.83 | 5.66 | 6.73 | 7.49 | |||||
Income From Continuing Operations Margin % | 4.87 | 5.15 | 4.8 | 4.35 | 4.93 | |||||
Net Income Margin % | 4.87 | 5.15 | 4.8 | 4.35 | 4.93 | |||||
Net Avail. For Common Margin % | 4.87 | 5.15 | 4.8 | 4.35 | 4.93 | |||||
Normalized Net Income Margin | 4.15 | 4.15 | 3.37 | 4 | 4.48 | |||||
Levered Free Cash Flow Margin | 4.46 | 1.66 | 1.09 | 3.42 | 1.58 | |||||
Unlevered Free Cash Flow Margin | 4.55 | 1.78 | 1.27 | 3.63 | 1.79 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.86 | 1.84 | 1.93 | 1.96 | 1.87 | |||||
Fixed Assets Turnover | 4.37 | 4.25 | 4.46 | 4.51 | 4.06 | |||||
Receivables Turnover (Average Receivables) | 9.37 | 9.33 | 9.46 | 9.27 | 8.9 | |||||
Inventory Turnover (Average Inventory) | 13.56 | 12.39 | 11.84 | 11.61 | 11.07 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.66 | 1.54 | 1.72 | 1.66 | 1.69 | |||||
Quick Ratio | 1.09 | 0.91 | 1.03 | 1.03 | 1.02 | |||||
Operating Cash Flow to Current Liabilities | 0.78 | 0.62 | 0.53 | 0.69 | 0.62 | |||||
Days Sales Outstanding (Average Receivables) | 38.86 | 39.03 | 38.47 | 40 | 40.91 | |||||
Days Outstanding Inventory (Average Inventory) | 26.84 | 29.37 | 30.75 | 31.95 | 32.88 | |||||
Average Days Payable Outstanding | 28.28 | 28.82 | 27.94 | 28.83 | 29.08 | |||||
Cash Conversion Cycle (Average Days) | 37.42 | 39.58 | 41.28 | 43.12 | 44.71 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 19.15 | 13.81 | 14.44 | 13.88 | 18.05 | |||||
Total Debt / Total Capital | 16.07 | 12.14 | 12.62 | 12.19 | 15.29 | |||||
LT Debt/Equity | 17.33 | 12.02 | 12.73 | 11.98 | 16.39 | |||||
Long-Term Debt / Total Capital | 14.54 | 10.56 | 11.12 | 10.52 | 13.88 | |||||
Total Liabilities / Total Assets | 34.15 | 32.74 | 33.36 | 34.14 | 35.48 | |||||
EBIT / Interest Expense | 43.07 | 36.08 | 20.25 | 19.66 | 22.17 | |||||
EBITDA / Interest Expense | 65.63 | 53.26 | 31.63 | 29.4 | 31.95 | |||||
(EBITDA - Capex) / Interest Expense | 41.67 | 28.61 | 18.54 | 18.11 | 16.99 | |||||
Total Debt / EBITDA | 0.67 | 0.52 | 0.59 | 0.48 | 0.61 | |||||
Net Debt / EBITDA | 0.47 | 0.52 | 0.49 | 0.38 | 0.59 | |||||
Total Debt / (EBITDA - Capex) | 1.05 | 0.98 | 1.01 | 0.78 | 1.14 | |||||
Net Debt / (EBITDA - Capex) | 0.74 | 0.98 | 0.84 | 0.62 | 1.1 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.87 | 5.8 | 15.66 | 11.89 | 4.77 | |||||
Gross Profit, 1 Yr. Growth % | 21.64 | 4.38 | 7.08 | 24.53 | 12.06 | |||||
EBITDA, 1 Yr. Growth % | 24.98 | 2.49 | 1.22 | 28.6 | 12.3 | |||||
EBITA, 1 Yr. Growth % | 25.54 | 6.48 | -2.77 | 31.58 | 15.33 | |||||
EBIT, 1 Yr. Growth % | 26.67 | 6.11 | -3.59 | 32.98 | 16.57 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 11.85 | 11.89 | 7.63 | 1.53 | 18.74 | |||||
Net Income, 1 Yr. Growth % | 11.85 | 11.89 | 7.63 | 1.53 | 18.74 | |||||
Normalized Net Income, 1 Yr. Growth % | 27.35 | 5.63 | -5.73 | 33.09 | 17.12 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 10.72 | 10.93 | 6.67 | 0.91 | 17.36 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.55 | 9.89 | 17.74 | 11.11 | 7.49 | |||||
Inventory, 1 Yr. Growth % | 4.68 | 26.85 | 19.18 | 6.24 | 10.79 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.44 | 12.3 | 8.02 | 13.12 | 19.27 | |||||
Total Assets, 1 Yr. Growth % | 4.66 | 9.71 | 10.65 | 9.42 | 10.64 | |||||
Tangible Book Value, 1 Yr. Growth % | 18.44 | 11.47 | 15.27 | 12.64 | 11.32 | |||||
Common Equity, 1 Yr. Growth % | 11.65 | 12.07 | 9.62 | 8.14 | 8.38 | |||||
Cash From Operations, 1 Yr. Growth % | 55.04 | -11.8 | -4.38 | 49.28 | -5.3 | |||||
Capital Expenditures, 1 Yr. Growth % | -28.95 | 30.32 | -9.18 | 18.1 | 36.92 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -631.92 | -60.61 | -22.92 | 250.22 | -51.69 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -710.95 | -58.72 | -16.6 | 220.8 | -48.45 | |||||
Dividend Per Share, 1 Yr. Growth % | 15.89 | 8 | 5.03 | 13.35 | 12.22 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 14.93 | 9.76 | 10.62 | 13.76 | 8.27 | |||||
Gross Profit, 2 Yr. CAGR % | 20.14 | 12.68 | 5.72 | 15.48 | 18.13 | |||||
EBITDA, 2 Yr. CAGR % | 23.46 | 13.18 | 1.69 | 14.09 | 20.18 | |||||
EBITA, 2 Yr. CAGR % | 19.97 | 15.62 | 1.53 | 13.11 | 23.19 | |||||
EBIT, 2 Yr. CAGR % | 20.15 | 15.94 | 0.92 | 13.23 | 24.51 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 15.28 | 11.87 | 9.74 | 4.53 | 9.8 | |||||
Net Income, 2 Yr. CAGR % | 15.28 | 11.87 | 9.74 | 4.53 | 9.8 | |||||
Normalized Net Income, 2 Yr. CAGR % | 18.88 | 15.98 | -0.44 | 12.01 | 24.85 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 14.09 | 10.83 | 8.78 | 3.75 | 8.83 | |||||
Accounts Receivable, 2 Yr. CAGR % | 18.03 | 6.16 | 13.75 | 14.38 | 9.29 | |||||
Inventory, 2 Yr. CAGR % | 18.18 | 15.24 | 22.96 | 12.53 | 8.49 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 23.69 | 8.82 | 10.14 | 10.54 | 16.15 | |||||
Total Assets, 2 Yr. CAGR % | 20.47 | 7.16 | 10.18 | 10.03 | 10.03 | |||||
Tangible Book Value, 2 Yr. CAGR % | 12.45 | 14.9 | 13.35 | 13.95 | 11.97 | |||||
Common Equity, 2 Yr. CAGR % | 13.26 | 11.86 | 10.84 | 8.88 | 8.26 | |||||
Cash From Operations, 2 Yr. CAGR % | 43.82 | 16.94 | -8.16 | 19.48 | 18.9 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.72 | -3.78 | 8.79 | 3.57 | 27.16 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 437.72 | 44.75 | -45.21 | 64.3 | 30.07 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 449.55 | 58.81 | -41.63 | 63.57 | 28.59 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.9 | 11.88 | 6.5 | 9.11 | 12.78 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.04 | 11.81 | 11.69 | 11.04 | 10.68 | |||||
Gross Profit, 3 Yr. CAGR % | 12.95 | 14.64 | 10.78 | 11.65 | 14.33 | |||||
EBITDA, 3 Yr. CAGR % | 12.86 | 16.04 | 8.93 | 9.97 | 13.49 | |||||
EBITA, 3 Yr. CAGR % | 12.7 | 15.29 | 8.98 | 10.7 | 13.84 | |||||
EBIT, 3 Yr. CAGR % | 12.6 | 15.28 | 8.86 | 10.64 | 14.33 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 9.74 | 14.14 | 10.44 | 6.93 | 9.07 | |||||
Net Income, 3 Yr. CAGR % | 9.74 | 14.14 | 10.44 | 6.93 | 9.07 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.85 | 14.29 | 8.08 | 9.68 | 13.69 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 8.6 | 13.03 | 9.42 | 6.09 | 8.1 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.81 | 15.25 | 9.89 | 12.86 | 12.03 | |||||
Inventory, 3 Yr. CAGR % | 17.27 | 21 | 16.54 | 17.11 | 11.94 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 23.36 | 19.77 | 8.55 | 11.12 | 13.38 | |||||
Total Assets, 3 Yr. CAGR % | 16.95 | 16.77 | 8.31 | 9.93 | 10.23 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.22 | 12.12 | 15.02 | 13.11 | 13.06 | |||||
Common Equity, 3 Yr. CAGR % | 12.65 | 12.86 | 11.11 | 9.93 | 8.71 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.4 | 22.19 | 9.35 | 7.98 | 10.57 | |||||
Capital Expenditures, 3 Yr. CAGR % | 7 | 5.76 | -5.61 | 11.81 | 13.66 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 31.45 | 124.99 | 16.88 | 1.68 | 9.25 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 32.26 | 131.88 | 27.68 | 3 | 11.31 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.24 | 10.59 | 9.55 | 8.74 | 10.14 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.31 | 10.04 | 9.67 | 12.58 | 10.31 | |||||
Gross Profit, 5 Yr. CAGR % | 14.53 | 12.08 | 10 | 14.97 | 13.67 | |||||
EBITDA, 5 Yr. CAGR % | 16.57 | 12.65 | 8.26 | 15.18 | 13.3 | |||||
EBITA, 5 Yr. CAGR % | 15.38 | 13 | 8.09 | 14.32 | 14.45 | |||||
EBIT, 5 Yr. CAGR % | 15.27 | 12.94 | 7.78 | 14.35 | 14.87 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 13.53 | 10.65 | 9.74 | 10.2 | 10.18 | |||||
Net Income, 5 Yr. CAGR % | 15.3 | 9.02 | 9.74 | 10.2 | 10.18 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.9 | 12.46 | 6.76 | 13.27 | 14.5 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.26 | 9.51 | 8.67 | 9.22 | 9.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.25 | 10.21 | 12.58 | 14.9 | 9.65 | |||||
Inventory, 5 Yr. CAGR % | 16.74 | 14.05 | 19.51 | 17.54 | 13.25 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 20.08 | 18.32 | 17.89 | 15.99 | 11.53 | |||||
Total Assets, 5 Yr. CAGR % | 15.36 | 13.35 | 14.2 | 14.03 | 8.99 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.13 | 15.37 | 13.87 | 12.85 | 13.79 | |||||
Common Equity, 5 Yr. CAGR % | 13.27 | 12.78 | 11.92 | 11.25 | 9.96 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.69 | 17.02 | 6.42 | 21.1 | 13.08 | |||||
Capital Expenditures, 5 Yr. CAGR % | 15.96 | 14.8 | 7.71 | 4.88 | 6.34 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 18.01 | 58.82 | -7.38 | 97.96 | 21.99 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 18.38 | 58.68 | -4.65 | 101.24 | 28.04 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.3 | 11.38 | 8.14 | 9.99 | 10.83 |
- Stock Market
- Equities
- CWK Stock
- Financials Cranswick plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















